Cargando…

Lipoprotein Profile Modifications during Gestation: A Current Approach to Cardiovascular risk surrogate markers and Maternal-fetal Unit Complications

Several changes occur in lipid metabolism during gestation due to hormonal and metabolic changes, which are essential to satisfy the nutritional demands of the maternal-fetal unit development. The gestation shows two distinct periods that begin with fat accumulation, mainly in maternal adipose tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Ana Paula Caires dos, Couto, Ricardo David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309395/ https://www.ncbi.nlm.nih.gov/pubmed/29768640 http://dx.doi.org/10.1055/s-0038-1642600

Ejemplares similares

N6-methyladenosine modifications in maternal-fetal crosstalk and gestational diseases
por: Wu, Suqi, et al.
Publicado: (2023)

Fetal mitochondrial DNA in maternal plasma in surrogate pregnancies: Detection and topology
por: Ma, Mary‐Jane L., et al.
Publicado: (2020)

Animal models for clinical and gestational diabetes: maternal and fetal outcomes
por: Kiss, Ana CI, et al.
Publicado: (2009)

Maternal and fetal genetic contribution to gestational weight gain
por: Warrington, N M, et al.
Publicado: (2018)

The Impact of Ethnicity on Fetal and Maternal Outcomes of Gestational Diabetes
por: Filardi, Tiziana, et al.
Publicado: (2022)

Gestationally dependent immune organization at the maternal-fetal interface
por: Moore, Amber R., et al.
Publicado: (2022)

Maternal and Fetal Effects of Gestational Vitamin D Concentration
por: Kwon, Ki-Wook, et al.
Publicado: (2023)

Acute Atherosis Lesions at the Fetal-Maternal Border: Current Knowledge and Implications for Maternal Cardiovascular Health
por: Pitz Jacobsen, Daniel, et al.
Publicado: (2021)

Fetal and Maternal Outcomes in Pregnancies Complicated with Fetal Macrosomia
por: Alsammani, Mohamed Alkahatim, et al.
Publicado: (2012)

Fibrinogen for the prediction of severe maternal complications in placental abruption with fetal death after 24 weeks of gestation
por: Atallah, Anthony, et al.
Publicado: (2022)

Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
por: Mandel, Anna, et al.
Publicado: (2022)

Imaging as a surrogate marker of drug efficacy in cardiovascular disease
por: Tarkin, Jason M, et al.
Publicado: (2019)

Complications in multiple gestation pregnancy: A cross-sectional study of ten maternal-fetal medicine centers in China
por: Wei, Jun, et al.
Publicado: (2016)

Does the Change in the Diagnostic Criteria for Gestational Diabetes in Poland Affect Maternal and Fetal Complications? A Prospective Study
por: Cichocka, Edyta, et al.
Publicado: (2022)

Seasonal variations in incidence and maternal–fetal outcomes of gestational diabetes
por: Meek, C. L., et al.
Publicado: (2020)

Lipoprotein Ratios as Surrogate Markers for Insulin Resistance in South Indians with Normoglycemic Nondiabetic Acute Coronary Syndrome
por: Rajappa, Medha, et al.
Publicado: (2014)

Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
por: Kawamoto, Ryuichi, et al.
Publicado: (2010)

Lipoprotein (a), an independent cardiovascular risk marker
por: Saeedi, Ramesh, et al.
Publicado: (2016)

Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain
por: Kallak, Theodora Kunovac, et al.
Publicado: (2017)

Breast Arterial Calcification: A Potential Surrogate Marker for Cardiovascular Disease
por: Suh, Jung-Won, et al.
Publicado: (2018)

Effects of insulin on placental, fetal and maternal outcomes in gestational diabetes mellitus
por: Arshad, Rabia, et al.
Publicado: (2014)

Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome
por: Stapleton, P. A., et al.
Publicado: (2018)

Maternal and Fetal Metabolites in Gestational Diabetes Mellitus: A Narrative Review
por: Vladu, Ionela Mihaela, et al.
Publicado: (2022)

Maternal, Fetal, and Neonatal Outcomes of Gestation in Women with and Without Brucella Infection
por: Majzoobi, Mohammad Mahdi, et al.
Publicado: (2023)

Effect of Genetically Reduced Maternal Myostatin on Late Gestation Maternal, Fetal, and Placental Metabolomes in Mice
por: Opoku, Ruth, et al.
Publicado: (2023)

Evaluating the Agreement of Risk Categorization for Fetal Down Syndrome Screening between Ultrasound-Based Gestational Age and Menstrual-Based Gestational Age by Maternal Serum Markers
por: Chaksuwat, Pakorn, et al.
Publicado: (2018)

Elevated galectin-3 in women with gestational diabetes mellitus, a new surrogate for cardiovascular disease in women
por: Talmor-Barkan, Yeela, et al.
Publicado: (2020)

The applicability of current global cardiovascular risk scores and cardiovascular surrogates in chronic obstructive pulmonary disease
por: Khanji, Mohammed Y, et al.
Publicado: (2016)

Fetal cerebral three-dimensional power Doppler vascularization indices and their relationships with maternal glucose levels in pregnancies complicated with gestational diabetes
por: Pérez-Martín, Sara M, et al.
Publicado: (2022)

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
por: Sibal, Latika, et al.
Publicado: (2011)

Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model
por: Ngamprasertwong, Pornswan, et al.
Publicado: (2016)

The psychological well-being and prenatal bonding of gestational surrogates
por: Lamba, N, et al.
Publicado: (2018)

Influence of Sex on Gestational Complications, Fetal-to-Neonatal Transition, and Postnatal Adaptation
por: Lorente-Pozo, Sheila, et al.
Publicado: (2018)

Maternal undernutrition does not alter Sertoli cell numbers or the expression of key developmental markers in the mid-gestation ovine fetal testis
por: Andrade, Luis P, et al.
Publicado: (2013)

The Gestational Effects of Maternal Bone Marker Molecules on Fetal Growth, Metabolism and Long-Term Metabolic Health: A Systematic Review
por: Dimas, Angelos, et al.
Publicado: (2022)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
por: Komatsu, Tomohiro, et al.
Publicado: (2021)

Maternal Psychological and Biological Factors Associated to Gestational Complications
por: Ramiro-Cortijo, David, et al.
Publicado: (2021)

Surrogate Adiposity Markers and Mortality
por: Khan, Irfan, et al.
Publicado: (2023)

Evaluation of fetal diaphragm excursion and thickness in term pregnancies complicated with pre-gestational and gestational diabetes mellitus
por: Acmaz, Gokhan, et al.
Publicado: (2022)

Maternal and fetal outcomes in pregnancies complicated by overweight and obesity
por: Vernini, Joice Monaliza, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bgdm3hu369d45kc6gt369lus8m